Category: CollagenVI – Articles

COVID-19 VACCINES AND NEUROMUSCULAR DISEASES, 23
4 de May de 20214 de May de 2021
Post

COVID-19 VACCINES AND NEUROMUSCULAR DISEASES, 23

On February 23rd, 2021, we participated in one of the seminars organized by ASEM Catalonia: COVID-19 vaccine and neuromuscular diseases, a virtual lecture given by Dr. Olivé, neurologist at Sant Pau University Hospital and Dr. Natera, neuropediatrician at the Sant Joan de Déu University Hospital in Barcelona. Here you will find a summary of the...

An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil
30 de March de 20216 de October de 2021
Post

An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil

In recent years, news have emerged from time to time that point to the potential benefit of some drugs for congenital muscular dystrophy patients. Although they do not hope to cure the disease, these drugs do seek to alleviate the harmful effects that a dysfunctional collagen matrix causes on muscle cells, slowly promoting their destruction....